Monday, July 22, 2019 4:00:40 PM
Although, a small deal, it validates multiple things for the company. Alfasigma sees value in Brilacidin. Other companies may look at the company more seriously since they have one licensing deal. And, Leo has been proven not to be a liar when saying he has a term sheet.
I'm not surprised that the deal is smaller than most expected, but, the next deal should be better. Hoping it's for Brilacidin OM.
In Reply to 'slcimmuno'
Yes! A first Deal... BRI UP/UPS delivering. $24m w 6% royalties for a PoC trial (no placebo) is a great deal imo with a legit Global Rx with IBD expertise.
Has been a LONG time in coming fer sure but will take it — and hopefully with more coming. Domino Effect. Maybe BRI OM the next Deal to drop? Research cap on, did some quick Googling and Alfasigma seems like an ideal IBD partner:
> Top 100 Global Rx ($1.2bn rev, 3000 employees)
> Big in GI: developed Xifaxan for IBS, an antibacterial (hmmm maybe partly why they like BRI) $1bn in sales in US alone in 2015
> Partnered with Salix (Bausch) (the other big GI specialty Rx) in late 2018 to work on formulations in Crohns
> Even had a Super Bowl commercial (250k YouTube views)
AS looks super well positioned to bring BRI UP/UPS to market, a new treatment for patients, and maybe our first revenue stream. Plus love how AS is waiting in wings possibly to option BRI Oral... UC / Crohns... that’s where the real patient need is (non Biologics) and the Big $$$ are (Protagonist, Theravance ... $50-100m upfront, $1bn in total deal size)
Looks like IPIX is back and ready to start rumbling again!
Up 86%
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM